(FLS) Flowserve - Overview
Stock: Pumps, Seals, Valves, Actuators, Aftermarket
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.51% |
| Yield on Cost 5y | 2.40% |
| Yield CAGR 5y | 1.23% |
| Payout Consistency | 76.3% |
| Payout Ratio | 23.7% |
| Risk 5d forecast | |
|---|---|
| Volatility | 25.6% |
| Relative Tail Risk | -5.59% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.79 |
| Alpha | 15.67 |
| Character TTM | |
|---|---|
| Beta | 1.513 |
| Beta Downside | 1.651 |
| Drawdowns 3y | |
|---|---|
| Max DD | 38.76% |
| CAGR/Max DD | 1.01 |
Description: FLS Flowserve January 07, 2026
Flowserve Corporation (NYSE:FLS) designs, manufactures, distributes, and services industrial flow-management equipment across North America, Europe, the Middle East, Africa, and the Asia-Pacific. It operates two primary segments: the Flowserve Pump Division (FPD), which supplies custom-engineered and pre-configured pumps, mechanical seals, and aftermarket services, and the Flow Control Division (FCD), which provides isolation and control valves, actuators, positioners, and related field services. The company’s product portfolio is sold under the Valtek, Argus, Worcester, Limitorque, and Durco brands to end-markets that include oil & gas, power generation, chemicals, water management, mining, food & beverage, steel, and pulp & paper.
Key recent metrics: FY 2023 revenue reached $4.3 billion, with an adjusted EBITDA margin of 13.5 % and a free-cash-flow conversion of ≈ 85 %. The order backlog stood at roughly $2.4 billion, indicating a 55 % coverage of FY 2024 earnings, and roughly 30 % of sales are tied to oil-and-gas capital-expenditure cycles, making the segment sensitive to commodity price swings and the broader energy-transition push. A secular driver for Flowserve is the global increase in water-infrastructure spending, projected by the World Bank to exceed $1 trillion by 2030, which underpins demand for pumps and valve solutions in municipal and industrial water-treatment projects.
For a deeper quantitative view, the ValueRay platform provides a granular breakdown of Flowserve’s cash-flow dynamics and valuation sensitivities.
Piotroski VR‑10 (Strict, 0-10) 8.5
| Net Income: 346.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 1.36 > 1.0 |
| NWC/Revenue: 32.58% < 20% (prev 31.52%; Δ 1.07% < -1%) |
| CFO/TA 0.09 > 3% & CFO 505.9m > Net Income 346.2m |
| Net Debt (1.15b) to EBITDA (675.8m): 1.70 < 3 |
| Current Ratio: 2.03 > 1.5 & < 3 |
| Outstanding Shares: last quarter (128.4m) vs 12m ago -2.98% < -2% |
| Gross Margin: 34.30% > 18% (prev 0.32%; Δ 3398 % > 0.5%) |
| Asset Turnover: 84.38% > 50% (prev 82.86%; Δ 1.53% > 0%) |
| Interest Coverage Ratio: 7.47 > 6 (EBITDA TTM 675.8m / Interest Expense TTM 77.7m) |
Altman Z'' 6.09
| A: 0.27 (Total Current Assets 3.04b - Total Current Liabilities 1.50b) / Total Assets 5.71b |
| B: 0.75 (Retained Earnings 4.26b / Total Assets 5.71b) |
| C: 0.10 (EBIT TTM 580.3m / Avg Total Assets 5.60b) |
| D: 1.13 (Book Value of Equity 3.91b / Total Liabilities 3.45b) |
| Altman-Z'' Score: 6.09 = AAA |
Beneish M -3.28
| DSRI: 0.78 (Receivables 1.03b/1.28b, Revenue 4.73b/4.56b) |
| GMI: 0.94 (GM 34.30% / 32.16%) |
| AQI: 0.98 (AQ_t 0.34 / AQ_t-1 0.34) |
| SGI: 1.04 (Revenue 4.73b / 4.56b) |
| TATA: -0.03 (NI 346.2m - CFO 505.9m) / TA 5.71b) |
| Beneish M-Score: -3.28 (Cap -4..+1) = AA |
What is the price of FLS shares?
Over the past week, the price has changed by +9.35%, over one month by +17.39%, over three months by +23.22% and over the past year by +36.95%.
Is FLS a buy, sell or hold?
- StrongBuy: 8
- Buy: 1
- Hold: 2
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the FLS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 82.2 | -3.8% |
| Analysts Target Price | 82.2 | -3.8% |
| ValueRay Target Price | 112 | 31% |
FLS Fundamental Data Overview February 07, 2026
P/E Forward = 20.3666
P/S = 2.2036
P/B = 4.4778
P/EG = 2.0347
Revenue TTM = 4.73b USD
EBIT TTM = 580.3m USD
EBITDA TTM = 675.8m USD
Long Term Debt = 1.44b USD (from longTermDebt, two quarters ago)
Short Term Debt = 85.5m USD (from shortTermDebt, last quarter)
Debt = 1.91b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.15b USD (from netDebt column, last quarter)
Enterprise Value = 11.48b USD (10.33b + Debt 1.91b - CCE 760.2m)
Interest Coverage Ratio = 7.47 (Ebit TTM 580.3m / Interest Expense TTM 77.7m)
EV/FCF = 26.39x (Enterprise Value 11.48b / FCF TTM 435.0m)
FCF Yield = 3.79% (FCF TTM 435.0m / Enterprise Value 11.48b)
FCF Margin = 9.20% (FCF TTM 435.0m / Revenue TTM 4.73b)
Net Margin = 7.32% (Net Income TTM 346.2m / Revenue TTM 4.73b)
Gross Margin = 34.30% ((Revenue TTM 4.73b - Cost of Revenue TTM 3.11b) / Revenue TTM)
Gross Margin QoQ = 34.79% (prev 34.55%)
Tobins Q-Ratio = 2.01 (Enterprise Value 11.48b / Total Assets 5.71b)
Interest Expense / Debt = 1.02% (Interest Expense 19.6m / Debt 1.91b)
Taxrate = 21.0% (US default 21%)
NOPAT = 458.5m (EBIT 580.3m * (1 - 21.00%))
Current Ratio = 2.03 (Total Current Assets 3.04b / Total Current Liabilities 1.50b)
Debt / Equity = 0.87 (Debt 1.91b / totalStockholderEquity, last quarter 2.19b)
Debt / EBITDA = 1.70 (Net Debt 1.15b / EBITDA 675.8m)
Debt / FCF = 2.64 (Net Debt 1.15b / FCF TTM 435.0m)
Total Stockholder Equity = 2.19b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.18% (Net Income 346.2m / Total Assets 5.71b)
RoE = 15.81% (Net Income TTM 346.2m / Total Stockholder Equity 2.19b)
RoCE = 16.01% (EBIT 580.3m / Capital Employed (Equity 2.19b + L.T.Debt 1.44b))
RoIC = 12.47% (NOPAT 458.5m / Invested Capital 3.68b)
WACC = 9.82% (E(10.33b)/V(12.24b) * Re(11.49%) + D(1.91b)/V(12.24b) * Rd(1.02%) * (1-Tc(0.21)))
Discount Rate = 11.49% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -1.42%
[DCF Debug] Terminal Value 72.19% ; FCFF base≈398.7m ; Y1≈409.6m ; Y5≈457.9m
Fair Price DCF = 37.38 (EV 5.90b - Net Debt 1.15b = Equity 4.75b / Shares 127.1m; r=9.82% [WACC]; 5y FCF grow 2.72% → 2.90% )
EPS Correlation: 78.86 | EPS CAGR: 109.0% | SUE: 2.46 | # QB: 3
Revenue Correlation: 88.61 | Revenue CAGR: 11.19% | SUE: -1.19 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.85 | Chg30d=-0.024 | Revisions Net=+0 | Analysts=8
EPS current Year (2026-12-31): EPS=4.00 | Chg30d=+0.024 | Revisions Net=+6 | Growth EPS=+9.8% | Growth Revenue=+5.1%
EPS next Year (2027-12-31): EPS=4.41 | Chg30d=-0.000 | Revisions Net=+2 | Growth EPS=+10.4% | Growth Revenue=+4.4%